CurveBeam AI Limited (ASX:CVB)
Australia
· Delayed Price · Currency is AUD 0.0660
+0.0010 (1.54%)
At close: Mar 6, 2026
CurveBeam AI Revenue
CurveBeam AI had revenue of 4.96M AUD in the half year ending December 31, 2025, with 40.63% growth. This brings the company's revenue in the last twelve months to 12.15M, up 53.72% year-over-year. In the fiscal year ending June 30, 2025, CurveBeam AI had annual revenue of 12.10M with 85.33% growth.
Revenue (ttm)
12.15M
Revenue Growth
+53.72%
P/S Ratio
2.59
Revenue / Employee
243.04K
Employees
50
Market Cap
31.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.10M | 5.57M | 85.33% |
| Jun 30, 2024 | 6.53M | -1.53M | -18.97% |
| Jun 30, 2023 | 8.06M | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | 795.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Atomo Diagnostics | 3.92M |
| ImpediMed | 14.23M |
| Control Bionics | 6.07M |
| CleanSpace Holdings | 20.66M |
| Nova Eye Medical | 33.05M |
| HeraMED | 431.61K |
| Micro-X | 16.90M |
| CONNEQT Health | 5.80M |